Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical and Experimental Pharmacology & Physiology. Supplement|January 1, 1995
Effect of felodipine treatment and withdrawal on blood pressure and cardiovascular structure in New Zealand genetically hypertensive ratsJ M Ledingham, E L Phelan, M A Cross, et al.
Journal of Cardiovascular Pharmacology|January 1, 1990
Sensitivity to Ca2+ and the effects of a calcium channel antagonist in resistance vessels from two strains of genetically hypertensive ratN J Cassie, M A Cross, E L Phelan, et al.
Circulation Research|August 1, 1978
Blood pressure and vascular resistance in genetically hypertensive rats treated at birth with 6-hydroxydopamineD W Clark, D R Jones, E L Phelan, et al.
The New Zealand Medical Journal|December 8, 1982
A pilot study to test the feasibility of salt restriction in a communityB I Thaler, J M Paulin, E L Phelan, et al.
Clinical and Experimental Pharmacology & Physiology|March 1, 1994
Remodelling of resistance arteries by treatment with enalapril in the New Zealand genetically hypertensive ratJ M Ledingham, E L Phelan, M Cross, et al.
Clinical Science and Molecular Medicine. Supplement|June 1, 1975
Prazosin: preliminary clinical and pharmacological observationsP Bolli, A J Wood, E L Phelan, et al.
The New Zealand Medical Journal|December 26, 1984
Iodide excretion in a salt-restriction trialF O Simpson, B I Thaler, J M Paulin, et al.
Journal of Hypertension|April 1, 1995
Heart mass and blood pressure have separate genetic determinants in the New Zealand genetically hypertensive (GH) ratE L Harris, E L Phelan, C M Thompson, et al.
Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Relationship of blood pressure to sodium excretion in a population surveyF O Simpson, H J Waal-Manning, P Bolli, et al.
Pageof 2